Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 03, 2025

Get In Touch

Merck, Eisai to shut down late stage trial of liver cancer therapy Pharma News

Merck, Eisai to shut down late stage trial of liver cancer therapy

  • 31 October 2025
  • 3 days ago

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension Pharma News

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension

  • 28 October 2025
  • 5 days ago

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer Pharma News

Merck gets USFDA priority review for 2 applications for Keytruda, Keytruda Qlex in combo with Padcev for bladder cancer

  • 25 October 2025
  • 1 week ago

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Pharma News

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

  • 21 September 2025
  • 1 month ago

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval Oncology

Merck injectable version of blockbuster cancer therapy Keytruda gets USFDA approval

  • 20 September 2025
  • 1 month ago

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer Oncology

Merck gets USFDA Breakthrough Therapy Designation for Raludotatug deruxtecan for Platinum-Resistant Ovarian Cancer

  • 17 September 2025
  • 1 month ago

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials Neurology

Merck KGaA Multiple Sclerosis Drug Fails In Late-Stage Trials

  • 04 July 2025
  • 3 months ago

Recent News

GLP-1 Receptor Agonists Linked to Lower Risk of Ea...

  • 03 November, 2025

Ketogenic diet may protect against stress experien...

  • 03 November, 2025

STORM-PE Trial: Mechanical Thrombectomy Shows Supe...

  • 03 November, 2025

AIIMS INI CET January 2026 admit cards released

  • 03 November, 2025

3 pharma students drown in Payyambalam beach in Ke...

  • 03 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.